Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.8K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.8K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K
Standard Precaution01:26

Standard Precaution

3.6K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
3.6K
Birth Control Methods01:22

Birth Control Methods

7.4K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.4K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

5.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Put us in, Coach: the case for recognizing the ID/Addiction workforce.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

A Study Protocol to Increase Engagement in Evidence-Based Hospital and Community-Based Care Using a Serious Injection-Related Infections Checklist and Intensive Peer for Hospitalized PWID (ShaPe).

Substance use & addiction journal·2025
Same author

U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations.

Harm reduction journal·2025
Same author

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

JAMA·2024
Same author

Equal Access, Equal Outcomes: Telehealth Utilization Around the COVID-19 Pandemic among People Living with HIV and Opioid Use Disorder in the Deep South.

AIDS and behavior·2024
Same author

Substance Use Stigma Among Clinical and Nonclinical Staff Who Provide Care for People With HIV in the Deep South: A Pilot Training Intervention.

The Journal of the Association of Nurses in AIDS Care : JANAC·2024

Related Experiment Video

Updated: Apr 20, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.7K

Barrier methods for human immunodeficiency virus prevention.

Ellen F Eaton1, Craig J Hoesley1

  • 1Division of Infectious Disease, University of Alabama, Birmingham, 229 Tinsley Harrison Tower, 1720 Second Avenue South, Birmingham, AL 35294, USA.

Infectious Disease Clinics of North America
|December 3, 2014
PubMed
Summary

Condoms are effective HIV barriers, but usage issues limit effectiveness. Topical and rectal microbicides are promising prevention tools, though none are FDA-approved yet.

Keywords:
Female condomsHuman immunodeficiency virus preventionMale condomsMicrobicides

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.3K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.5K

Related Experiment Videos

Last Updated: Apr 20, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.7K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.3K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.5K

Area of Science:

  • Sexual health
  • Infectious disease prevention
  • Virology

Background:

  • Condoms are the primary method for preventing sexual transmission of human immunodeficiency virus (HIV).
  • Male and female condoms demonstrate high effectiveness rates (80-90%) when used correctly.
  • Suboptimal adherence and improper usage significantly reduce the real-world efficacy of condoms.

Purpose of the Study:

  • To review the current landscape of barrier methods for HIV prevention.
  • To highlight the potential of microbicides as an additional HIV prevention strategy.
  • To discuss the development status of topical and rectal microbicides.

Main Methods:

  • Review of existing literature on condom effectiveness and microbicide research.
  • Analysis of preclinical and clinical trial data for microbicide candidates.
  • Examination of the role of anal receptive sex in HIV transmission.

Main Results:

  • Condoms, while effective, are limited by user adherence and correct application.
  • Over 50 topical microbicide compounds have been investigated in the past decade.
  • No topical microbicide products have received US Food and Drug Administration (FDA) approval to date.
  • Development of rectal microbicides is underway to address transmission risks during anal receptive sex.

Conclusions:

  • Condoms remain a crucial, albeit imperfect, tool for HIV prevention.
  • Microbicides represent a significant area of research for novel HIV prevention strategies.
  • Further research and development are needed to bring effective microbicides to market, particularly for rectal use.